4//SEC Filing
Zook Anthony P. 4
Accession 0001077183-25-000096
CIK 0001077183other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:13 PM ET
Size
12.1 KB
Accession
0001077183-25-000096
Insider Transaction Report
Form 4
Zook Anthony P.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-05-06$7.88/sh+18,900$148,919→ 18,900 total(indirect: By Trust)
Holdings
- 11,336
Common Stock
- 8,353
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying) - 8,672
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying) - 12,254
Restricted Stock Unit
Exercise: $0.00From: 2025-06-01→ Common Stock (12,254 underlying) - 729,927
Stock Option (Right to Buy)
Exercise: $10.44Exp: 2035-04-01→ Common Stock (729,927 underlying) - 421,496
Restricted Stock Unit
Exercise: $0.00→ Common Stock (421,496 underlying)
Footnotes (4)
- [F1]Once vested, the shares of common stock are not subject to expiration.
- [F2]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.
- [F3]On April 1, 2025, Mr. Zook was granted 729,927 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F4]On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001582393
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:13 PM ET
- Size
- 12.1 KB